Print
Email
Print Edition StoriesThursday, February 4, 2010
Tepha pulls in $3M for medical biomaterials
By Mass High Tech staff
MHT's Julie Donnelly: Pharmaceuticals find drug development partners in colleges
Funding drugs for rare diseases
MHT's Julie Donnelly: Life science startups finding investments
Tepha Inc., a Lexington-based medical devices company, has raised almost $3 million in financing, according to a regulatory filing with the U.S. Securities and Exchange Commission.
The privately held company makes absorbable biomaterials, including polymers and elastomers, used in medical devices such as surgical sutures and meshes. The company did not disclose its investors in this latest funding round. However, it last reported a $10.7 million financing in 2007, led by The Vertical Group, based in Summit, N.J., with participation from Integra Ventures, Novartis Venture Fund and Westfield Life Sciences Fund.
Tepha was founded in 1998 as a spinoff of a collaboration between its sister company Metabolix Inc. in Cambridge and Children’s Hospital Boston to develop technologies related to cardiac tissue engineering.
RSS Feeds
Comments
Please Login/Register to post comments.
No comments have been added or approved.